D.E. Shaw & Co’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $92.1M | Buy |
|
|||||
2025
Q1 | – | Sell |
|
|||||
2024
Q4 | $15.6M | Buy |
|
|||||
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $1.15M | Buy |
|
|||||
2023
Q3 | $219K | Buy |
|
|||||
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $2.43M | Sell |
|
|||||
2022
Q4 | $7.56M | Sell |
|
|||||
2022
Q3 | $19.9M | Sell |
|
|||||
2022
Q2 | $35.8M | Buy |
|
|||||
2022
Q1 | $30.7M | Buy |
|
|||||
2021
Q4 | $381K | Sell |
|
|||||
2021
Q3 | $1.17M | Buy |
|
|||||
2021
Q2 | $311K | Buy |
|
|||||
2021
Q1 | – | Sell |
|
|||||
2020
Q4 | $3.82M | Sell |
|
|||||
2020
Q3 | $5.12M | Sell |
|
|||||
2020
Q2 | $6.2M | Sell |
|
|||||
2020
Q1 | $7.1M | Buy |
|
|||||
2019
Q4 | $6.46M | Sell |
|
|||||
2019
Q3 | $12.2M | Buy |
|
|||||
2019
Q2 | $9.18M | Sell |
|
|||||
2019
Q1 | $17M | Buy |
|
|||||
2018
Q4 | $11.4M | Sell |
|
|||||
2018
Q3 | $29.7M | Buy |
|
|||||
2018
Q2 | $17.6M | Buy |
|
|||||
2018
Q1 | $14.1M | Sell |
|
|||||
2017
Q4 | $46M | Sell |
|
|||||
2017
Q3 | $69.3M | Buy |
|
|||||
2017
Q2 | $54M | Sell |
|
|||||
2017
Q1 | $50.4M | Sell |
|
|||||
2016
Q4 | $50.8M | Buy |
|
|||||
2016
Q3 | $33.4M | Buy |
|
|||||
2016
Q2 | $23.8M | Buy |
|
|||||
2016
Q1 | $14M | Sell |
|
|||||
2015
Q4 | $19M | Buy |
|
|||||
2015
Q3 | $6.23M | Buy |
|
|||||
2015
Q2 | $6.54M | Sell |
|
|||||
2015
Q1 | $14.2M | Buy |
|
|||||
2014
Q4 | $6.69M | Sell |
|
|||||
2014
Q3 | $14.9M | Sell |
|
|||||
2014
Q2 | $17.8M | Buy |
|
|||||
2014
Q1 | $9.49M | Sell |
|
|||||
2013
Q4 | $10M | Sell |
|
|||||
2013
Q3 | $16.5M | Buy |
|
|||||
2013
Q2 | $8.25M | Buy |
|